AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 277: G455-G462, 1999;
0193-1857/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matkowskyj, K. A.
Right arrow Articles by Benya, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matkowskyj, K. A.
Right arrow Articles by Benya, R. V.
Vol. 277, Issue 2, G455-G462, August 1999

Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model

Kristina A. Matkowskyj, Jorge A. Marrero, Robert E. Carroll, Alexey V. Danilkovich, Richard M. Green, and Richard V. Benya

Department of Medicine, University of Illinois at Chicago, and Chicago Veterans Affairs Medical Center, West Side Division, Chicago, Illinois 60612

Without transplantation, ~50-90% of all patients with fulminant hepatic failure (FHF) die. This poor outcome is due in part to the absence of an appropriate animal model, which would allow for a greater understanding of the pathophysiology of this syndrome. Given the reports of liver injury in humans and livestock fed cycad palm nuts on the island of Guam, we hypothesized that the active ingredient azoxymethane (AOM) could cause FHF. We therefore evaluated AOM in C57BL/6J mice. Histologically, we observed microvesicular steatosis 2 h, sinusoidal dilatation 4 h, and centrilobular necrosis 20 h after AOM administration, and transmission electron microscopy showed that this agent causes mitochondrial injury. FHF was associated with all four stages of encephalopathy, as well as by a prodromal period of decreased eating and drinking lasting ~15 h before the development of stage I encephalopathy (i.e., loss of scatter reflex). Late encephalopathy was associated with increased arterial ammonia, decreased serum glucose, and evidence of brain edema (astrocyte swelling). We show that AOM-induced FHF is highly reproducible, without evidence of lot-to-lot variability, and is dose dependent. These findings therefore suggest that AOM is an excellent agent for the study of FHF, as well as indicate that Guamanian FHF may be due to AOM found in unwashed cycad palm nuts.

hepatic injury; hepatic encephalopathy; astrocytes; central nervous system edema


This article has been cited by other articles:


Home page
Cell Growth Differ.Home page
R. E. Carroll, K. A. Matkowskyj, M. S. Tretiakova, J. F. Battey, and R. V. Benya
Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer
Cell Growth Differ., July 1, 2000; 11(7): 385 - 393.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online